Natera Signatera Validation Study Published in JCO PO Shows Superior Prognostic Value in Testicular Cancer
Natera Inc. (NASDAQ:NTRA) is one of the best growth stocks to buy now.
Natera Inc. (NTRA)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Zevenbergen Capital Investments Nancy Zevenbergen | 394,565 | $63,513,129 | -3% | 1.23% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.56 | 19,011 | $562,054.51 | 420,000 | 2022-05-12 | Filing | |
| $28.81 | 159,783 | $4,603,348.23 | 400,989 | 2022-05-12 | Filing | |
| $28.09 | 41,026 | $1,152,358.80 | 241,026 | 2022-05-12 | Filing | |
| $33.49 | 40,695 | $1,362,798.23 | 1,291,584 | 2022-03-16 | Filing | |
| $32.59 | 85,903 | $2,799,982.51 | 1,250,889 | 2022-03-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $179.29 | 337 | $60,421.13 | 28,032 | 2025-10-17 | Filing | |
| $178.58 | 413 | $73,754.28 | 28,369 | 2025-10-17 | Filing | |
| $179.35 | 275 | $49,321.55 | 28,032 | 2025-10-17 | Filing | |
| $178.66 | 475 | $84,863.55 | 28,307 | 2025-10-17 | Filing | |
| $176.63 | 423 | $74,712.46 | 236,112 | 2025-10-15 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 356,609 | $57,403,350 | 0.06% | |
| 2. | 305,722 | $49,212,070 | 0.07% | |
| 3. | 47,037 | $7,571,562 | 1.85% | |
| 4. | 45,170 | $7,271,015 | 0.01% | |
| 5. | 38,591 | $6,211,994 | 0.05% |
News See All
12 Best Growth Stocks to Buy Now
On October 1, Keith Lerner, Chief Investment Officer at Truist Wealth, appeared on CNBC and stated that the shutdown fears are muted, and investors are not overly concerned right now.
Natera (NTRA) Provides an Update on its Intellectual Property Litigation With NeoGenomics
Natera, Inc. (NASDAQ:NTRA) is one of the best hot large cap stocks to buy according to hedge funds. On August 29, Natera, Inc.
11 Hot Large Cap Stocks to Buy According to Hedge Funds
On August 30, Ryan Detrick, Carson Group chief market strategist, appeared on CNBC's ‘Closing Bell’ to talk about his thoughts on the markets.
Natera, Inc. (NASDAQ:NTRA) Q2 2025 Earnings Call Transcript
Operator: Hello. Welcome to Natera's 2025 Second Quarter Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today, August 7, 2025.
14 Best Aggressive Growth Stocks to Buy According to Analysts
On Thursday, August 7, the Dow Jones Industrial Average fell by 0.51% to give back some gains and close lower. The S&P 500 also experienced a small decline of 0.08%.
Evercore ISI Initiates Coverage on Natera (NTRA) with Outperform Rating
Natera, Inc. (NASDAQ:NTRA) is one of the high growth stocks outside tech analysts are bullish on. Evercore ISI Group has initiated coverage on Natera Inc.
10 High Growth Stocks Outside Tech Analysts Are Bullish On
Even though the Nasdaq and S&P 500 are hitting record highs, a lot of that growth is coming from just a few big tech and communication companies.
RBC Capital Maintains a Buy on Natera (NTRA) With a $251 PT
Natera, Inc. (NASDAQ:NTRA) is one of the best strong buy healthcare stocks to buy now. On June 30, RBC Capital analyst Conor McNamara maintained a Buy rating on Natera, Inc.
10 Best Strong Buy Healthcare Stocks to Buy Now
On July 21, Jared Holz, Mizuho health care sector strategist, appeared on CNBC's 'The Exchange' to talk about whether any opportunity plays exist within the healthcare sector, and what pains the sector...